pubmed-article:8044943 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8044943 | lifeskim:mentions | umls-concept:C0035173 | lld:lifeskim |
pubmed-article:8044943 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:8044943 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
pubmed-article:8044943 | lifeskim:mentions | umls-concept:C0027051 | lld:lifeskim |
pubmed-article:8044943 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:8044943 | lifeskim:mentions | umls-concept:C1623258 | lld:lifeskim |
pubmed-article:8044943 | lifeskim:mentions | umls-concept:C0016018 | lld:lifeskim |
pubmed-article:8044943 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:8044943 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:8044943 | lifeskim:mentions | umls-concept:C1442770 | lld:lifeskim |
pubmed-article:8044943 | lifeskim:mentions | umls-concept:C0040044 | lld:lifeskim |
pubmed-article:8044943 | lifeskim:mentions | umls-concept:C1515980 | lld:lifeskim |
pubmed-article:8044943 | lifeskim:mentions | umls-concept:C1521801 | lld:lifeskim |
pubmed-article:8044943 | lifeskim:mentions | umls-concept:C0205087 | lld:lifeskim |
pubmed-article:8044943 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:8044943 | pubmed:dateCreated | 1994-8-26 | lld:pubmed |
pubmed-article:8044943 | pubmed:abstractText | Thrombolytic therapy reduces mortality after acute myocardial infarction, even when treatment is initiated relatively late after onset of symptoms. The mechanism underlying this survival benefit is incompletely understood. | lld:pubmed |
pubmed-article:8044943 | pubmed:language | eng | lld:pubmed |
pubmed-article:8044943 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8044943 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:8044943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8044943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8044943 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8044943 | pubmed:month | Aug | lld:pubmed |
pubmed-article:8044943 | pubmed:issn | 0009-7322 | lld:pubmed |
pubmed-article:8044943 | pubmed:author | pubmed-author:ArmstrongP... | lld:pubmed |
pubmed-article:8044943 | pubmed:author | pubmed-author:TherouxPP | lld:pubmed |
pubmed-article:8044943 | pubmed:author | pubmed-author:MorganC DCD | lld:pubmed |
pubmed-article:8044943 | pubmed:author | pubmed-author:NaylorC DCD | lld:pubmed |
pubmed-article:8044943 | pubmed:author | pubmed-author:TopolE JEJ | lld:pubmed |
pubmed-article:8044943 | pubmed:author | pubmed-author:SteinbergJ... | lld:pubmed |
pubmed-article:8044943 | pubmed:author | pubmed-author:DorianPP | lld:pubmed |
pubmed-article:8044943 | pubmed:author | pubmed-author:HochmanJ SJS | lld:pubmed |
pubmed-article:8044943 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8044943 | pubmed:volume | 90 | lld:pubmed |
pubmed-article:8044943 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8044943 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8044943 | pubmed:pagination | 746-52 | lld:pubmed |
pubmed-article:8044943 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:meshHeading | pubmed-meshheading:8044943-... | lld:pubmed |
pubmed-article:8044943 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:8044943 | pubmed:articleTitle | Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy. | lld:pubmed |
pubmed-article:8044943 | pubmed:affiliation | Division of Cardiology, St Luke's-Roosevelt Hospital Center, New York, NY 10025. | lld:pubmed |
pubmed-article:8044943 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8044943 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:8044943 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:8044943 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:8044943 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:8044943 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8044943 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8044943 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8044943 | lld:pubmed |